Does CERTOLIZUMAB PEGOL Cause Nasopharyngitis? 5,295 Reports in FDA Database

Q: Does CERTOLIZUMAB PEGOL cause Nasopharyngitis?

5,295 reports of Nasopharyngitis have been filed with the FDA for CERTOLIZUMAB PEGOL, representing 5.3% of all CERTOLIZUMAB PEGOL adverse event reports.

Q: How dangerous is Nasopharyngitis from CERTOLIZUMAB PEGOL?

Of 5,295 reports, 1,293 (24.4%) resulted in death and 1,921 required hospitalization.

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 5,295 reports of Nasopharyngitis have been filed in association with CERTOLIZUMAB PEGOL (Cimzia). This represents 5.3% of all adverse event reports for CERTOLIZUMAB PEGOL.

5,295

Reports of Nasopharyngitis with CERTOLIZUMAB PEGOL

5.3%

of all CERTOLIZUMAB PEGOL reports

1,293

Deaths

1,921

Hospitalizations

How Dangerous Is Nasopharyngitis From CERTOLIZUMAB PEGOL?

Of the 5,295 reports, 1,293 (24.4%) resulted in death, 1,921 (36.3%) required hospitalization, and 1,423 (26.9%) were considered life-threatening.